IP Library Granted Patent US 8,586,725
Granted Patent B2
US 8,586,725 · App. 12/521,695 · Granted Nov 19, 2013

MicroRNAome

Inventors: Jordan Cummins (Baltimore, MD); Victor Velculescu (Dayton, MD); Kenneth W. Kinzler (Bel Air, MD); Bert Vogelstein (Baltimore, MD)
Assignee: The Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,586,725
App. No.
12/521,695
Granted
Nov 19, 2013
Kind
B2
Abstract

MicroRNAs (miRNAs) are a class of small noncoding RNAs that have important regulatory roles in multicellular organisms. The public miRNA database contains 321 human miRNA sequences, 234 of which have been experimentally verified. To explore the possibility that additional miRNAs are present in the human genome, we have developed an experimental approach called miRNA serial analysis of gene expression (miRAGE) and used it to perform the largest experimental analysis of human miRNAs to date. Sequence analysis of 273,966 small RNA tags from human colorectal cells allowed us to identify 200 known mature miRNAs, 133 novel miRNA candidates, and 112 previously uncharacterized miRNA* forms. To aid in the evaluation of candidate miRNAs, we disrupted the Dicer locus in three human colorectal cancer cell lines and examined known and novel miRNAs in these cells. The miRNAs are useful to diagnose and treat cancers.

Claims (9)

1. An isolated polynucleotide of approximately 17-250 nucleotides comprising a sequence selected from the group consisting of: (a) SEQ ID NO: 469 and (b) a sequence which is at least 84% identical to (a).

2. The polynucleotide of claim 1 wherein the polynucleotide is from 18-25 nucleotides in length.

3. The polynucleotide of claim 1 wherein the polynucleotide is from 19-24 nucleotides in length.

4. The polynucleotide of claim 1 wherein the polynucleotide is from 21-23 nucleotides in length.

5. The polynucleotide of claim 1 wherein the polynucleotide is DNA.

6. The polynucleotide of claim 1 wherein the polynucleotide is RNA.

7. The polynucleotide of claim 1 wherein the polynucleotide is labeled with a detectable label.

8. The polynucleotide of claim 1 wherein the polynucleotide is attached to a solid support.

9. The polynucleotide of claim 1 wherein the polynucleotide is attached to a solid support at a defined location.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 13, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044428/0244 →
Continuity (1)
Related Publication 20100137413A1 · Jun 3, 2010